| Literature DB >> 28317947 |
Firdaus Fabrice Hannanu1, Thomas A Zeffiro2, Laurent Lamalle3, Olivier Heck4, Félix Renard5, Antoine Thuriot6, Alexandre Krainik7, Marc Hommel8, Olivier Detante9, Assia Jaillard10.
Abstract
While motor recovery following mild stroke has been extensively studied with neuroimaging, mechanisms of recovery after moderate to severe strokes of the types that are often the focus for novel restorative therapies remain obscure. We used fMRI to: 1) characterize reorganization occurring after moderate to severe subacute stroke, 2) identify brain regions associated with motor recovery and 3) to test whether brain activity associated with passive movement measured in the subacute period could predict motor outcome six months later. Because many patients with large strokes involving sensorimotor regions cannot engage in voluntary movement, we used passive flexion-extension of the paretic wrist to compare 21 patients with subacute ischemic stroke to 24 healthy controls one month after stroke. Clinical motor outcome was assessed with Fugl-Meyer motor scores (motor-FMS) six months later. Multiple regression, with predictors including baseline (one-month) motor-FMS and sensorimotor network regional activity (ROI) measures, was used to determine optimal variable selection for motor outcome prediction. Sensorimotor network ROIs were derived from a meta-analysis of arm voluntary movement tasks. Bootstrapping with 1000 replications was used for internal model validation. During passive movement, both control and patient groups exhibited activity increases in multiple bilateral sensorimotor network regions, including the primary motor (MI), premotor and supplementary motor areas (SMA), cerebellar cortex, putamen, thalamus, insula, Brodmann area (BA) 44 and parietal operculum (OP1-OP4). Compared to controls, patients showed: 1) lower task-related activity in ipsilesional MI, SMA and contralesional cerebellum (lobules V-VI) and 2) higher activity in contralesional MI, superior temporal gyrus and OP1-OP4. Using multiple regression, we found that the combination of baseline motor-FMS, activity in ipsilesional MI (BA4a), putamen and ipsilesional OP1 predicted motor outcome measured 6 months later (adjusted-R2 = 0.85; bootstrap p < 0.001). Baseline motor-FMS alone predicted only 54% of the variance. When baseline motor-FMS was removed, the combination of increased activity in ipsilesional MI-BA4a, ipsilesional thalamus, contralesional mid-cingulum, contralesional OP4 and decreased activity in ipsilesional OP1, predicted better motor outcome (djusted-R2 = 0.96; bootstrap p < 0.001). In subacute stroke, fMRI brain activity related to passive movement measured in a sensorimotor network defined by activity during voluntary movement predicted motor recovery better than baseline motor-FMS alone. Furthermore, fMRI sensorimotor network activity measures considered alone allowed excellent clinical recovery prediction and may provide reliable biomarkers for assessing new therapies in clinical trial contexts. Our findings suggest that neural reorganization related to motor recovery from moderate to severe stroke results from balanced changes in ipsilesional MI (BA4a) and a set of phylogenetically more archaic sensorimotor regions in the ventral sensorimotor trend, in which OP1 and OP4 processes may complement the ipsilesional dorsal motor cortex in achieving compensatory sensorimotor recovery.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28317947 PMCID: PMC5342999 DOI: 10.1016/j.nicl.2017.01.023
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Fig. 1Inclusion flow chart.
Fig. 2Four axial slices representative showing stroke lesion extent in 21 patients (FLAIR images).
Baseline stroke features in the 21 patients.
| N | Age | Sex | Lesion side | ART | Volume cm3 | Infarct arterial territory | Artery occlusion | Thrombolysis | Stroke diagnosis and related risk factors |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 46 | M | L | 24 | 115 | MCA | No | tpa | Persistent foramen ovale |
| 2 | 51 | M | L | 8 | 97 | ICA | No | tpa | ICA dissection |
| 3 | 38 | F | L | 2 | 47 | ACA + superf MCA | No | No | ICA dissection; migraine |
| 4 | 53 | M | L | 24 | 181 | MCA | No | No | AF |
| 5 | 50 | M | R | 0 | 19 | Deep MCA | No | tpa | Hypertension; dyslipidemia |
| 6 | 60 | F | L | 23 | 119 | ICA | No | No | ICA stenosis (50%) |
| 7 | 48 | F | L | 20 | 123 | Superf MCA | No | No | Oral contraceptive; tobacco |
| 8 | 59 | M | L | 23 | 73 | MCA | No | No | Hypertension; dyslipidemia |
| 9 | 57 | M | R | 0 | 36 | MCA | No | No | Hypertension; tobacco |
| 10 | 31 | M | L | 16 | 101 | MCA | No | tpa | Tobacco; alcohol |
| 11 | 45 | M | R | 0 | 60 | Superf MCA | No | No | Tobacco |
| 12 | 64 | M | L | 24 | 227 | ICA | Yes | No | ICA occlusion (diabetes, dyslipidemia; tobacco) |
| 13 | 41 | F | L | 14 | 112 | MCA | No | tpa | ICA occlusion (dissection); oral contraceptive |
| 14 | 52 | M | R | 0 | 83 | MCA | No | tpa | ICA dissection |
| 15 | 59 | F | R | 0 | 52 | MCA | No | tpa | AF |
| 16 | 42 | F | R | 0 | 55 | MCA | No | tpa | Oral contraceptive |
| 17 | 59 | M | L | 8 | 43 | MCA | No | No | Atheroma (dyslipidemia; tobacco, alcohol) |
| 18 | 65 | M | L | 10 | 72 | MCA | No | No | AF; hypertension; dyslipidemia; tobacco |
| 19 | 57 | M | L | 13 | 33 | Superf MCA | No | tpa | ICA dissection; hypertension |
| 20 | 62 | M | L | 5 | 70 | MCA | No | tpa | Hypertension; dyslipidemia |
| 21 | 67 | M | L | 26 | 150 | MCA | No | no | Hypertension; sleep apnea syndrome |
| Total or mean (SD) | 52.7 (9.6) | 6 F | 6 R | 16.0 (8.0) | 88.4 (52.6) | 3 ICA/18 MCA | 1 ICA occlusion | 10 tpa | 6 hypertension/4 ICA dissection/3 AF |
M indicates male, F female, L left, R Right, Superf MCA superficial middle cerebral artery, ICA indicates internal carotid artery; AF atrial fibrillation, ART aphasia rapid test; higher score indicates severity. Artery occlusion indicates Artery occlusion at admission time. There was no persistent carotid artery occlusion at the time of the fMRI session.
Comparisons of patients characteristics from the fMRI study (N = 21) and the non-fMRI group (N = 9).
| Variables | fMRI patients (N = 21) | non fMRI patients (N = 9) | Kruskal Wallis test | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | p value | Asymp. Sig. | |
| Age | 52.67 | 9.63 | 48.89 | 12.30 | 0.37 | 0.48 |
| Lesion volume [cc] | 119.08 | 80.46 | 158.08 | 97.46 | 0.26 | 0.38 |
| NIHSS V2 | 13.86 | 4.90 | 15.13 | 5.06 | 0.54 | 0.51 |
| Barthel V2 | 47.14 | 33.15 | 36.88 | 32.06 | 0.46 | 0.39 |
| ART V2 | 16.00 | 8.02 | 18.20 | 8.44 | 0.61 | 0.43 |
| Rankin V2 | 3.67 | 0.58 | 4.13 | 0.35 | 0.05 | 0.04 |
| mFMS V2 | 39.76 | 30.59 | 26.63 | 19.26 | 0.27 | 0.41 |
| NIHSS V6 | 8.10 | 3.99 | 11.33 | 6.36 | 0.10 | 0.24 |
| Barthel V6 | 85.95 | 20.10 | 68.75 | 37.58 | 0.12 | 0.32 |
| ART V6 | 11.36 | 8.64 | 15.83 | 10.78 | 0.34 | 0.28 |
| Rankin V6 | 2.81 | 0.60 | 3.33 | 0.50 | 0.03 | 0.03 |
| mFMS V6 | 54.29 | 29.33 | 36.63 | 28.49 | 0.13 | 0.09 |
V2 indicates inclusion visit at baseline one month post-stroke; V6, Six month follow-up visit; ART = aphasia rapid test; mFMS = motor Fugl-Meyer subscore (max = 100). Treatment (no CSM; low doses; high doses).
Correlations between motor Fugl Meyer scores and MRI parameters.
| MRI variables | Number | Motor Fugl Meyer scale correlations | |||
|---|---|---|---|---|---|
| Inclusion (1 month) | 6 months | ||||
| r | P | r | p | ||
| 1. | 0.007 | 0.001 | |||
| 2. | 0.033 | 0.050 | |||
| 3. | 0.020 | 0.008 | |||
| Right MI-4p | 4. | 0.215 | 0.350 | 0.191 | 0.406 |
| 5. | 0.002 | 0.000 | |||
| 6. | 0.011 | 0.013 | |||
| Left vPMC - BA 6 (-40,-12,56) | 7. | 0.300 | 0.187 | 0.246 | 0.283 |
| Right vPMC - BA 6 (64,8,22) | 8. | 0.313 | 0.167 | 0.274 | 0.23 |
| 9. | 0.015 | 0.001 | |||
| 10. | 0.005 | 0.001 | |||
| 11. | 0. | 0.009 | 0.021 | ||
| Right MCC | 12. | 0.352 | 0.117 | 0.344 | 0.127 |
| 13. | 0.017 | 0.005 | |||
| 14. | 0.030 | 0.041 | |||
| 15. | 0.035 | 0.018 | |||
| Right SI-3b | 16. | 0.403 | 0.070 | 0.455 | 0.038 |
| Left OP1 - SII | 17. | 0.145 | 0.530 | 0.105 | 0.650 |
| 18. | 0.032 | 0.010 | |||
| Left OP4 | 19. | 0.206 | 0.370 | 0.061 | 0.792 |
| 20. | 0.006 | 0.010 | |||
| Right insula | 21. | 0.445 | 0.043 | 0.403 | 0.07 |
| Left insula | 22. | 0.371 | 0.098 | 0.383 | 0.086 |
| 23. | 0.037 | 0.040 | |||
| Left BA 44 | 24. | 0.286 | 0.208 | 0.310 | 0.172 |
| Left thalamus (-16,-16,0) | 25. | 0.017 | 0.943 | 0.039 | 0.867 |
| Right thalamus (14,14,2) | 26. | 0.229 | 0.319 | 0.113 | 0.625 |
| Left putamen (-28,2,0) | 27. | 0.291 | 0.200 | 0.350 | 0.120 |
| Right putamen (26,2,0) | 28. | 0.087 | 0.708 | − 0.014 | 0.953 |
| Left lobule V | 29. | 0.335 | 0.138 | 0.427 | 0.053 |
| 30. | 0.011 | 0.001 | |||
| 31. | 0.046 | 0.006 | |||
| 32. | 0.023 | 0.005 | |||
| Left lobule VIIIa | 33. | − 0.099 | 0.668 | 0.254 | 0.267 |
| Right lobule VIIIa | 34. | − 0.021 | 0.929 | 0.011 | 0.963 |
| Lesion volume cm3 | − 0.349 | 0.121 | − 0.289 | 0.204 | |
| CST damage percent | − | − | |||
MI indicates primary motor area, SI primary somatosensory cortex, PMC premotor cortex, SMA, the supplementary motor area, MCC indicates the MidCingulate Cortex, OP the parietal operculum, lobule cerebellar hemispheric lobule. CST indicates corticospinal tract.
The added ‘aal’ indicates that the anatomical ROI was taken from the Automated_Anatomical_Labeling (AAL) atlas. Note that the other ROIs are provided by the SPM anatomical toolbox from the Juelich atlas.
The added ‘mta-aal’ indicates the common overlap between the sensorimotor region activated during a hand motor task in the meta-analysis (Favre et al., 2014) (see link) and (1) the precentral gyrus from the AAL atlas (Tzourio-Mazoyer et al., 2002) to obtain distinct functional ROIs representing the hand area within the dorsolateral PMC and within the ventrolateral PMC; (2) the thalamus from the AAL atlas and the cluster located within the thalamus in the meta-analysis.
Correlation is significant at the 0.01 level (2-tailed).
Correlation is significant at the 0.05 level (2-tailed); parameters are in bold characters for significant correlations.
Fig. 3T1-rendered montage of brain activity during passive movement in healthy controls and stroke patients in: (A) 24 healthy control and (B) 21 patients. Axial slices are shown for z = − 24, − 20, 20, 46 and 50 mm. An uncorrected threshold of p < 0.001 is used to allow visualization of the spatial distribution of activity and corresponding effect sizes. The color of the bar indicates the intensity of brain activity (t-statistic). The right hand is the referent hand for both controls and patients. The left hemisphere is represented on the left side of picture (neurologic convention). z MNI coordinates are indicated in the bottom left corner. Table S3 lists the peak coordinates and corresponding effect estimates.
Fig. 4T1-rendered montage of brain activations during passive movement for (A) Controls minus Patients comparison (z = − 24, 50 mm) and reverse (B) Patients minus Controls, z = 10, 50 mm). Threshold is p < 0.001. The color of the bar indicates the intensity of brain activity (t-statistic). The right hand is the referent hand for controls and patients. The left hemisphere is represented on the left side of picture (neurologic convention). z MNI coordinates are indicated in the bottom left corner. See Table S4 for details.
Coefficients of determination for predicting motor Fugl Meyer scale at 6 months follow-up based on baseline motor Fugl Meyer scale, treatment, and functional parameters (Model 1) and treatment and functional parameters (Model 2) using Linear regression and bootstrap with 1000 replications 2. Contribution of FMS without fMRI variables is 54%.
| Model | R | R2 | Adjusted R2 | SE | Change statistics | Durbin Watson | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| R2 change | F change | df1 | df2 | Sig. F change | ||||||
| 1 | 0,949 | 0,900 | 0,867 | 10,694 | 0,150 | 7545 | 3 | 15 | 0,003 | 1838 |
| 2 | 0,985 | 0,969 | 0,956 | 6131 | 0,756 | 69,158 | 5 | 14 | 0,000 | 1929 |
Fig. 5Upper row: Predictive pattern for Model 1 including baseline motor-FMS including left putamen (green), OP1 (blue) and MI-4a (red). Lower row: Predictive pattern for Model 2 including - fMRI model- showing left OP1 (blue), and thalamus (pink), MI-4a (red), right anterior mid-cingulum (yellow) and OP4 (cyan). The left side indicates the lesioned hemisphere.
Coefficients of determination for predicting motor Fugl Meyer scale at 6 months follow-up based on clinical, structural, clinical + fMRI and fMRI measures (p < 0.05) after adjusting for stem cells treatment.
| Models | Baseline mFMS | Structural MRI | functional MRI + baseline FMS | Functional MRI |
|---|---|---|---|---|
| Adjusted R2 | 0.536 | 0.27 | 0.87 | 0.96 |
Bootstrap for coefficients in Models 1 and 2.
| Model | B | Bias | SE | Sig. (2-tailed) | 95% confidence interval | |
|---|---|---|---|---|---|---|
| Lower | Upper | |||||
| Model 1 | ||||||
| (Constant) | − 25,92 | 2,92 | 16,54 | 0,107 | − 49,50 | 10,75 |
| Treatment | 10,58 | − 0,33 | 4,18 | 0,036 | 0,73 | 17,26 |
| Baseline motor-FMS | 0,44 | 0,02 | 0,17 | 0,027 | 0,14 | 0,77 |
| OP1-SII ipsilesional | − 36,16 | − 1,62 | 16,58 | 0,045 | − 72,28 | − 5,34 |
| Putamen ipsilesional | 84,83 | − 6,97 | 34,51 | 0,040 | 6,82 | 136,04 |
| Putamen ipsilesional | 18,44 | 0,30 | 5,52 | 0,017 | 8,10 | 29,62 |
| Model 2 | ||||||
| (Constant) | − 25,34 | 0,69 | 7,32 | 0,014 | − 38,73 | − 9,20 |
| Treatment | 19,64 | − 0,21 | 2,30 | 0,001 | 14,96 | 24,00 |
| OP1-SII ipsilesional | − 39,77 | − 2,64 | 9,99 | 0,011 | − 61,56 | − 24,56 |
| BA4a ipsilesional | 17,62 | 0,49 | 2,68 | 0,004 | 14,17 | 24,14 |
| Thalamus ipsilesional | 79,02 | − 0,43 | 17,55 | 0,006 | 42,32 | 114,05 |
| OP4-PV contralesional | 134,23 | 0,45 | 27,08 | 0,004 | 77,85 | 186,21 |
| MCC contralesional | 184,76 | − 4,93 | 37,90 | 0,002 | 109,58 | 252,70 |
Fig. 6Plot of predicted and adjusted motor-FMS values for Model 1 (R2 = 0.797) and Model 2 (R2 = 0.932).